Allergan Pharmaceuticals Ireland Biologics Capacity Expansion Project Environmental Impact Statement (Volume 2)
Total Page:16
File Type:pdf, Size:1020Kb
Allergan Pharmaceuticals Ireland Biologics Capacity Expansion Project Environmental Impact Statement (Volume 2) For inspection purposes only. Consent of copyright owner required for any other use. July 2012 EPA Export 16-12-2013:23:16:13 Environmental Impact Statement Allergan Pharmaceuticals Ireland Biologics Capacity Expansion Project DOCUMENT CONTROL SHEET Client Allergan Pharmaceuticals Ireland Project Title Biologics Capacity Expansion Project For inspection purposes only. Consent of copyright owner required for any other use. Document Title Environmental Impact Statement (Volume 2) Document No. MDE1096Rp0001B List of No. of DCS TOC Text List of Tables This Document Figures Appendices Comprises 1 1 233 1 1 - Rev. Status Author(s) Reviewed By Approved By Office of Origin Issue Date F01 Final Various E. Oliviera P. Chadwick West Pier 31 July 2012 EPA Export 16-12-2013:23:16:13 Allergan Pharmaceuticals Ireland Biologics Capacity Expansion Project Environmental Impact Statement PREFACE The structure of the Environmental Impact Statement (EIS) for the proposed Allergan Biologics Capacity Expansion Project is laid out in the preface of each volume for clarity. The EIS consists of three volumes as follows: Volume 1 – Non-Technical Summary A non-technical summary of information contained in Volume 2. Volume 2 – Environmental Impact Statement This is the main volume of the EIS. It provides information on the location and scale of the proposed development, details on design and impacts on the environment (both positive and negative) as a result of the proposed development. Volume 3 – Technical Appendices Specialist technical reports on which information in Volume 2 is based. For inspection purposes only. Consent of copyright owner required for any other use. MDE1096Rp0001B i Rev F01 EPA Export 16-12-2013:23:16:14 Allergan Pharmaceuticals Ireland Biologics Capacity Expansion Project Environmental Impact Statement ACKNOWLEDGEMENTS This EIS has been prepared by RPS Group and their specialist environmental sub-consultants. Project Team Planning RPS Group Traffic RPS Group Human Beings RPS Group Air Quality and Climate RPS Group Noise RPS Group Landscape and Visual Impact RPS Group Terrestrial Ecology RPS Group Aquatic Ecology RPS Group Drainage RPS Group Soils Geology and Hydrogeology RPS Group Property RPS Group Material Assets RPS Group Archaeology, Architecture and Cultural Heritage Courtney Deery Heritage Consultancy For inspection purposes only. Consent of copyright owner required for any other use. MDE1096Rp0001B ii Rev F01 EPA Export 16-12-2013:23:16:14 Allergan Pharmaceuticals Ireland Biologics Capacity Expansion Project Environmental Impact Statement TABLE OF CONTENTS PREFACE................................................................................................................................................. I ACKNOWLEDGEMENTS....................................................................................................................... II 1 INTRODUCTION........................................................................................................................ 1 1.1 THE APPLICANT ............................................................................................................... 3 1.2 NEED FOR THE SCHEME ................................................................................................... 3 2 ENVIRONMENTAL IMPACT ASSESSMENT ........................................................................... 5 2.1 LEGISLATIVE PROVISIONS ................................................................................................ 5 2.2 INFORMATION TO BE CONTAINED IN AN EIS ....................................................................... 6 2.3 EIS GUIDANCE ................................................................................................................ 7 2.4 EIA PROCESS ................................................................................................................. 7 2.5 IDENTIFICATION OF LIKELY SIGNIFICANT IMPACTS .............................................................. 8 2.6 CONSULTATION................................................................................................................ 9 2.6.1 Planning Authority Pre Discussions ................................................................. 9 2.6.2 EIS Scoping Consultation................................................................................. 9 2.6.3 Statutory Consultation .................................................................................... 10 2.7 EIS SCOPE ................................................................................................................... 11 2.8 EIS STRUCTURE AND STUDY TEAM ................................................................................ 11 2.9 DIFFICULTIES ENCOUNTERED ......................................................................................... 12 3 DESCRIPTION OF THE PROJECT......................................................................................... 13 3.1 INTRODUCTION .............................................................................................................. 13 3.2 LOCATION OF THE PROPOSED DEVELOPMENT ................................................................. 13 For inspection purposes only. 3.3 BACKGROUND ...................................................Consent of copyright owner required for any................................................... other use. ......... 16 3.4 EXISTING ALLERGAN FACILITY ........................................................................................ 17 3.5 PROPOSED BIOLOGICS II BUILDING................................................................................. 17 3.6 PROPOSED UTILITIES ..................................................................................................... 18 3.6.1 Electrical Services .......................................................................................... 18 3.6.2 Mechanical Services ...................................................................................... 19 3.6.3 Heating, Ventilation and Air Conditioning (HVAC) ......................................... 19 3.6.4 Water Supply.................................................................................................. 19 3.6.5 Surface Water................................................................................................. 20 3.6.6 Foul Sewer ..................................................................................................... 20 3.6.7 Process Water................................................................................................ 20 3.6.8 Lighting ........................................................................................................... 21 3.6.9 Fire Services................................................................................................... 21 3.7 SERVICES YARD ............................................................................................................ 21 3.8 TRUCK LOADING DOCK .................................................................................................. 22 3.9 SITE ACCESS, INTERNAL ROADS AND CAR PARKING........................................................ 22 MDE1096Rp0001B iii Rev F01 EPA Export 16-12-2013:23:16:14 Allergan Pharmaceuticals Ireland Biologics Capacity Expansion Project Environmental Impact Statement 3.10 LANDSCAPING................................................................................................................ 23 3.11 PORTWEST SITE ACCESS............................................................................................... 23 3.12 CONSTRUCTION OF THE PROPSED DEVELOPMENT........................................................... 23 4 ALTERNATIVES CONSIDERED............................................................................................. 25 4.1 RATIONALE FOR SITE LOCATION ..................................................................................... 25 4.2 RATIONALE FOR SITE LAYOUT ........................................................................................ 25 5 PLANNING CONTEXT............................................................................................................. 29 5.1 INTRODUCTION .............................................................................................................. 29 5.2 STRATEGIC PLANNING CONTEXT .................................................................................... 29 5.2.1 National Spatial Strategy 2002-2020 ............................................................. 29 5.2.2 Regional Planning Guidelines for the West Region 2010-2022..................... 32 5.2.3 Mayo County Development Plan 2008-2014 ................................................. 35 5.3 STATUTORY PLANNING CONTEXT ................................................................................... 39 5.3.1 Westport Town & Environs Development Plan 2010-2016............................ 39 5.3.2 Variation No 3 of the Westport Town & Environs Development Plan 2010- 2016................................................................................................................ 45 5.4 PLANNING HISTORY ....................................................................................................... 47 5.4.1 IDA Business and Technology Park and Related Applications...................... 47 5.4.2 Allergan Planning Applications......................................................................